Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Boehringer Ingelheim Pharmaceuticals, Inc.
Current Parent CompanyBoehringer Ingelheim
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $13,500,000
Year: 2017
Date: December 20, 2017
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Violation Description: Boehringer Ingelheim Pharmaceuticals, Inc. agreed to pay $13.5 million to settle multistate litigation alleging deceptive and misleading representation and off-label marketing of its prescription drugs.
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: Germany
Ownership Structure of Current Parent: privately held
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.